series-b
Stage
1
Investors
About
Macromoltek develops polymer-based delivery systems for nucleic acid therapeutics to improve cellular delivery and stability of RNA and DNA drugs.
Explore Macromoltek's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.